References
  1. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75:1730-41.
  2. Sokolowska M, Lukasik Z, Agache I, Akdis CA, Akdis D, Akdis M, et al. Immunology of COVID-19: mechanisms, clinical outcome, diagnostics and perspectives - a report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy 2020;75:2445-2476.
  3. Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: A literature review. Rev Med Virol 2021;31:1-10.
  4. Wang JY, Pawankar R, Tsai HJ, Wu LSH, Kuo WH. COVID-19 and asthma, the good or the bad? Allergy 2021;76; 565-567
  5. Bonini S, Maltese G. COVID-19 Clinical trials: Quality matters more than quantity. Allergy 2020;75:2542-2547.
  6. Lee JH, Lee Y, Lee SY, Van Bever H, Lou H, Zhang L, Park HS. Management of Allergic Patients During the COVID-19 Pandemic in Asia. Allergy Asthma Immunol Res 2020;12:783-91.